|
Post by oldfishtowner on Oct 21, 2016 9:55:25 GMT -5
A couple of thoughts about what is going on, (1) "You will thank me later" from a man (MC) expecting something major. (2) Also, this on Twitter... Andy Oct 12 Andy @astrojny2 #mnkd #mannkind #afrezza What MNKD's partner RLS is up to. (link: charts.stocktwits.com/production/original_64511826.png?1476227301) charts.stocktwits.com/production/ori… Note that the RLS fact sheet is dated October 2016. It makes me believe that RLS is now shopping for venture capital. If so, is the funding needed for a clinical trial?
|
|
|
Post by kbrion77 on Oct 21, 2016 10:12:47 GMT -5
Can everyone throw out the theory of anything news related by now? Yesterday and today totally controlled by traders. Lets move on.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Oct 21, 2016 10:15:02 GMT -5
What do you think of Bayer with its Consumer Health division? That seems to be the rumor lately on some other MNKD forums. Bayer already has Claritin and they just may be interested in developing Epinephrine-TS. Another board, a different pipe dream?
|
|
|
Post by peppy on Oct 21, 2016 10:28:16 GMT -5
What do you think of Bayer with its Consumer Health division? That seems to be the rumor lately on some other MNKD forums. Bayer already has Claritin and they just may be interested in developing Epinephrine-TS. Another board, a different pipe dream? I think Bayer is busy buying Monsanto, making aspirin, morphine sulfate and heroin.
|
|
|
Post by 2011mnkdguy on Oct 21, 2016 10:31:38 GMT -5
10/20/2016, MannKind Corporation (NASDAQ:MNKD) negotiated 9.06 million shares against it an average volume of 3.37 million shares. The stock concluded the recent trade at $0.6097 with upbeat trend move of +29.9723%. The company has total market value of 291.47M.
|
|